Read news on SGLT2 with our app.
Read more in the app
SGLT2 inhibitors vs GLP-1 receptor agonists for kidney outcomes in individuals with type 2 diabetes - EurekAlert!
SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria - EurekAlert!
SGLT2 inhibitor empagliflozin is shown to be safe and effective for treating patients who have suffered a heart attack - EurekAlert
